Holen Sie sich die Stockscreener-App
0.604
14.93%
-0.106
Schlusskurs vom Vortag:
$0.71
Offen:
$0.715
24-Stunden-Volumen:
58,910
Relative Volume:
0.41
Marktkapitalisierung:
$3.87M
Einnahmen:
$1.10M
Nettoeinkommen (Verlust:
$-11.23M
KGV:
-0.2983
EPS:
-2.025
Netto-Cashflow:
$-6.61M
1W Leistung:
-25.56%
1M Leistung:
+11.85%
6M Leistung:
-22.06%
1J Leistung:
-32.88%
1-Tages-Spanne:
$0.60
$0.7249
1-Wochen-Bereich:
$0.60
$0.83
52-Wochen-Spanne:
$0.48
$3.09
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Firmenname
Matinas Biopharma Holdings Inc
Sektor
Branche
Telefon
908-443-1860
Adresse
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.604 | 3.87M | 1.10M | -11.23M | -6.61M | -2.025 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2020-01-09 | Eingeleitet | Aegis Capital | Buy |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
Matinas BioPharma Holdings Inc (MTNB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Institutional Confidence - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Matinas BioPharma Holdings Inc - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Matinas BioPharma (NYSEAM: MTNB) files $150M shelf to offer equity, debt and warrants - Stock Titan
MTNB Q4 2024 Earnings: Narrower-than-Expected Loss Highlights Cost DisciplineEarnings Manipulation Risk - newsline.com
MTNB Q4 2024 Earnings: EPS Beats Estimates as Biotech Continues Clinical DevelopmentEarnings Analysis - newsline.com
MTNB Q4 2024 Earnings: EPS Surprise Beat Amidst Pre-Revenue ChallengesMid-Term Outlook - newsline.com
Matinas Biopharma (MTNB) Slips to $0.79 as Stock Tests Key Support LevelExtension Target - newsline.com
MTNB Q4 2024 Earnings: Narrower-than-Expected Loss Boosts Investor SentimentEarnings Call Q&A - newsline.com
MSN Money - MSN
MTNB Stock Price, Quote & Chart | MATINAS BIOPHARMA HOLDINGS I (NYSEARCA:MTNB) - ChartMill
Matinas Biopharma (MTNB) Holds Near Support Amid Cautious Market SentimentAndrews Pitchfork - newsline.com
MTNB Q4 2024 Earnings: Narrowing Losses Surprise as Biotech Advances Pipeline Without RevenueEarnings Per Share - The Legal Advocate
MTNB Q4 2024 Earnings: Narrowed Loss Beats Estimates as Matinas Advances PipelineProfit Recovery Report - newsline.com
MTNB Q4 2024 Earnings: Matinas Biopharma Reports Narrower-Than-Expected LossAnalyst Consensus Shift - Newser
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAgape ATP (NASDAQ:ATPC), Co-Diagnostics - Benzinga
MTNB Technical Analysis | Trend, Signals & Chart Patterns | MATINAS BIOPHARMA HOLDINGS I (NYSEARCA:MTNB) - ChartMill
Matinas Biopharma Holdings, Inc. Common Stock (NY: MTNB - The Chronicle-Journal
TradingKey - TradingKey
What Matinas (MTNB) is building for next year | Q4 2024: Earnings Beat EstimatesProfessional Trade Ideas - Newser
Matinas BioPharma (NYSE: MTNB) warns on going concern amid low cash and NYSE notice - Stock Titan
The edge Matinas (MTNB) has in a competitive landscape (-1.09%) 2026-05-08Real Trader Insights - Newser
What Matinas (MTNB) does that makes it resilient (Institutional Selling) 2026-05-08Social Momentum Signals - newser.com
Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):